Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Behling

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Hepatology (Baltimore, Md.)|September 8, 2021
Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosisNobuharu Tamaki, Kento Imajo, Suzanne Sharpton, et al.
Journal of Hepatology|November 21, 2022
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetesVeeral Ajmera, Sandra Cepin, Kaleb Tesfai, et al.
Hepatology Communications|October 6, 2018
Hepatic Nuclear Receptor Expression Associates with Features of Histology in Pediatric Nonalcoholic Fatty Liver DiseaseErin E Elbel, Joel E Lavine, Michael Downes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 10, 2015
Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic SteatohepatitisAhilan Arulanandan, Brandon Ang, Ricki Bettencourt, et al.
Gut|April 22, 2021
Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver diseaseNobuharu Tamaki, Nagambika Munaganuru, Jinho Jung, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Investigating the Relationship Between Rare Genetic Variants and Fibrosis in Pediatric Nonalcoholic Fatty Liver DiseaseJulia Wattacheril, Sarah E Kleinstein, Patrick R Shea, et al.
Microsurgery|October 15, 2003
Non-viral human IL-10 gene expression reduces acute rejection in heterotopic auxiliary liver transplantation in ratsIn Chul Hong, Patricia M Mullen, Andrew F Precht, et al.
Gut|February 28, 2024
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASHRohit Loomba, Maral Amangurbanova, Ricki Bettencourt, et al.
Hepatology (Baltimore, Md.)|January 8, 2025
Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomesKimberly P Newton, Dulshan Jayasekera, Amanda L Blackford, et al.
Pancreas|March 15, 2002
Parathyroid hormone-related protein as a novel tumor marker in pancreatic adenocarcinomaMichael Bouvet, Stephanie R Nardin, Douglas W Burton, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|September 8, 2021
Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosisNobuharu Tamaki, Kento Imajo, Suzanne Sharpton, et al.
Journal of Hepatology|November 21, 2022
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetesVeeral Ajmera, Sandra Cepin, Kaleb Tesfai, et al.
Hepatology Communications|October 6, 2018
Hepatic Nuclear Receptor Expression Associates with Features of Histology in Pediatric Nonalcoholic Fatty Liver DiseaseErin E Elbel, Joel E Lavine, Michael Downes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 10, 2015
Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic SteatohepatitisAhilan Arulanandan, Brandon Ang, Ricki Bettencourt, et al.
Gut|April 22, 2021
Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver diseaseNobuharu Tamaki, Nagambika Munaganuru, Jinho Jung, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Investigating the Relationship Between Rare Genetic Variants and Fibrosis in Pediatric Nonalcoholic Fatty Liver DiseaseJulia Wattacheril, Sarah E Kleinstein, Patrick R Shea, et al.
Microsurgery|October 15, 2003
Non-viral human IL-10 gene expression reduces acute rejection in heterotopic auxiliary liver transplantation in ratsIn Chul Hong, Patricia M Mullen, Andrew F Precht, et al.
Gut|February 28, 2024
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASHRohit Loomba, Maral Amangurbanova, Ricki Bettencourt, et al.
Hepatology (Baltimore, Md.)|January 8, 2025
Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomesKimberly P Newton, Dulshan Jayasekera, Amanda L Blackford, et al.
Pancreas|March 15, 2002
Parathyroid hormone-related protein as a novel tumor marker in pancreatic adenocarcinomaMichael Bouvet, Stephanie R Nardin, Douglas W Burton, et al.
Pageof 9